NUC-7738

NUC-7738 · NuCana plc

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for NUC-7738, covering 2026-01-12 to 2026-01-12. Get the full timeline:

Most recent: Clinical Trial Update: A Safety, Pharmacokinetic and Clinical Activity Study of NUC-7738 in Patients With Advanced Solid Tumours and Lymphoma [Phase 1, Phase 2]

See pricing